ABC | Volume 111, Nº1, July 2018

Original Article Kalkan et al Adropin and Irisin Arq Bras Cardiol. 2018; 111(1):39-47 This is an open-access article distributed under the terms of the Creative Commons Attribution License 23. Butler AA, TamCS, Stanhope KL, Wolfe BM, Ali MR, O’KeeffeM, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic diseaseand increase after gastric bypass surgery in humans. J Clin Endocrinol Metab 2012;97(10):3783-91. 24. LovrenF,PanY,QuanA,SinghKK,ShuklaPC,GuptaM,etal.Adropinisanovel regulatorofendothelial function.Circulation.2010;122(11Suppl):S185-92. 25. Zhang C, Zhao L, Xu W, Li J, Wang B, Gu X, et al. [Correlation of serum adropin level with coronary artery disease]. Zhonghua Yi Xue Za Zhi. 2014;94(16):1255-7. 26. Zhao LP, Xu WT, Wang L, You T, Chan SP, Zhao X, et al. Serum adropin level in patients with stable coronary artery disease. Heart Lung Circ. 2015;24(10):975-9. 27. Yu HY, Zhao P, Wu MC, Liu J, Yin W. Serum adropin levels are decreased in patients with acutemyocardial infarction. Regul Pept. 2014;190-191:46-9. 28. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium- dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84(4):1589-96. 29. Novelle MG, Contreras C, Romero-Picó A, López M, Diéguez C. Irisin, two years later. Int J Endocrinol. 2013;2013:746281. 30. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002;85(1):51-66. 31. Aydin S, Aydin S, Kobat MA, Kalayci M, ErenMN, YilmazM, et al. Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides. 2014 Jun; 56:141-5. 32. ShenS,GaoR,BeiY,LiJ,ZhangH,ZhouY,etal.SerumIrisinPredictsMortality RiskinAcuteHeartFailurePatients.CellPhysiolBiochem.2017;42(2):615-22. 47